CARCINOMA, NEUROENDOCRINE
Clinical trials for CARCINOMA, NEUROENDOCRINE explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, NEUROENDOCRINE trials appear
Sign up with your email to follow new studies for CARCINOMA, NEUROENDOCRINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene test could tailor chemo doses for rare cancer
Disease control Recruiting nowThis phase 2 trial is testing whether adjusting the dose of the drug belinostat based on a person's genetics can make treatment safer and more effective for high-grade neuroendocrine carcinoma. About 60 adults will receive belinostat along with two other chemotherapy drugs, cispl…
Matched conditions: CARCINOMA, NEUROENDOCRINE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New hope for rare cancers: experimental drug ADCT-701 enters human trials
Disease control Recruiting nowThis early-phase trial tests a new drug called ADCT-701 in adults with rare cancers like neuroendocrine tumors, adrenal cancer, and malignant peripheral nerve sheath tumors. The goal is to find the safest dose and see if it can shrink tumors or slow disease. Participants receive …
Matched conditions: CARCINOMA, NEUROENDOCRINE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Rare cancer study seeks to unlock secrets of neuroendocrine tumors
Knowledge-focused Recruiting nowThis study aims to collect tissue samples and health information from 300 adults with neuroendocrine neoplasms (NENs), including adrenocortical carcinoma. Researchers will follow participants over time to understand how these rare cancers grow and respond to treatments. The goal …
Matched conditions: CARCINOMA, NEUROENDOCRINE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC